Cover Image
Market Research Report
Product code 
1085655

Pharmacovigilance Market, By Type of Clinical Trial Phases, By Type of Method, By Type of Service Providers, By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published: | Coherent Market Insights | 175 Pages | Delivery time: 2-3 business days

Price

Back to Top
Pharmacovigilance Market, By Type of Clinical Trial Phases, By Type of Method, By Type of Service Providers, By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Published: May 7, 2022
Coherent Market Insights
Content info: 175 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

Pharmacovigilance is a study of safety and efficacy of a medical product or drug. It is a science associated with the collection, detection, assessment, and prevention of adverse effects related with the medical product or drug. Pharmacovigilance comprises drug discovery and development, preclinical research, clinical research, and post marketing surveillance. Increasing prevalence of adverse drug reaction and implementation of safety regulations by government regulatory bodies is expected to fuel growth of the pharmacovigilance market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Pharmacovigilance market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Pharmacovigilance market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Accenture Plc, Bristol-Myers Squibb, Clinquest Group B.V., Cognizant Technology Solutions, Covance, Inc., GlaxoSmithKline, ICON, Plc, iGATE Corporation. Arriello, iMEDGlobal Corporation, Diamond Pharma Services, Infosys, Ergomed plc, inVentiv Health Inc., APCER Life Sciences, ArisGlobal, and Johnson and Johnson
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Pharmacovigilance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Pharmacovigilance market

Detailed Segmentation:

  • Global Pharmacovigilance Market, By Type of Clinical Trial Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
  • Global Pharmacovigilance Market, By Type of Method:
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
  • Global Pharmacovigilance Market, By Type of Service Providers:
    • In-House
    • Contract Outsourcing
  • Global Pharmacovigilance Market, By Region:
  • North America
    • By Clinical Trail Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
    • Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
    • Type of Service Providers
    • In-House
    • Contract Outsourcing
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Clinical Trail Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
    • Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
    • Type of Service Providers
    • In-House
    • Contract Outsourcing
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Clinical Trail Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
    • Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
    • Type of Service Providers
    • In-House
    • Contract Outsourcing
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Clinical Trail Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
    • Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
    • Type of Service Providers
    • In-House
    • Contract Outsourcing
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Clinical Trail Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
    • Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
    • Type of Service Providers
    • In-House
    • Contract Outsourcing
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Clinical Trail Phases:
    • Pre-clinical Studies
    • Clinical Trial Phase I
    • Clinical Trial Phase II
    • Clinical Trial Phase III
    • Post Marketing Surveillance or Phase IV
    • Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
    • Type of Service Providers
    • In-House
    • Contract Outsourcing
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • Accenture Plc *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Bristol-Myers Squibb
  • Clinquest Group B.V.
  • Cognizant Technology Solutions
  • Covance, Inc.
  • GlaxoSmithKline
  • ICON, Plc
  • iGATE Corporation
  • Arriello
  • iMEDGlobal Corporation
  • Diamond Pharma Services
  • Infosys
  • Ergomed plc
  • inVentiv Health Inc.
  • APCER Life Sciences
  • ArisGlobal
  • Johnson and Johnson
  • "*" marked represents similar segmentation in other categories in the respective section.
Product Code: CMI1047

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Clinical Trail Phases
    • Market Snippet, By Type of Method
    • Market Snippet, By Type of Service Providers
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Pharmacovigilance Market, By Clinical Trail Phases, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Pre-clinical Studies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Clinical Trial Phase I
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Clinical Trial Phase II
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Clinical Trial Phase III
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Post Marketing Surveillance or Phase IV
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Pharmacovigilance Market, By Type of Method, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Spontaneous Reporting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Intensified ADR Reporting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Targeted Reporting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Cohort Event Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • EHR Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Pharmacovigilance Market, By Type of Service Providers, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • In-House
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Contract Outsourcing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Pharmacovigilance Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Clinical Trail Phases, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, Type of Method, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, Type of Service Providers, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Clinical Trail Phases, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, Type of Method, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, Type of Service Providers, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Clinical Trail Phases, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, Type of Method, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, Type of Service Providers, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Clinical Trail Phases, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, Type of Method, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, Type of Service Providers, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Clinical Trail Phases, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, Type of Method, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, Type of Service Providers, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Clinical Trail Phases, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, Type of Method, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, Type of Service Providers, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

  • Company Profiles
    • Accenture Plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol-Myers Squibb
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Clinquest Group B.V.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cognizant Technology Solutions
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Covance, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline, ICON, Plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • iGATE Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • iMEDGlobal Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Diamond Pharma Services
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Infosys
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Ergomed plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • inVentiv Health Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • APCER Life Sciences
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ArisGlobal
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson and Johnson
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact